A close look at synergy and polyvalent action in medicinal plants Joanne Barnes Newsletter Article 18 February 2013 Pages: 3 - 4
What does the future hold for motor neurone disease treatment? Newsletter Article 18 February 2013 Pages: 5 - 5
Atorvastatin cost saving compared with other statins Newsletter Article 18 February 2013 Pages: 7 - 7
Complete tumour cure using HSV thymidine kinase gene therapy? Newsletter Article 18 February 2013 Pages: 8 - 8
New thrombolytics look as good as alteplase Tracey EarlCarmen Walsh Newsletter Article 18 February 2013 Pages: 9 - 10
Gene therapy technique promising for muscular dystrophy Newsletter Article 18 February 2013 Pages: 10 - 10
Fetal immunisation induces a protective immune response Newsletter Article 18 February 2013 Pages: 10 - 10
Tacrolimus reduces acute rejection in renal transplantation Newsletter Article 18 February 2013 Pages: 11 - 11
Better BP control has reduced the prevalence of LV hypertrophy Newsletter Article 18 February 2013 Pages: 12 - 12
Meropenem wages war against paediatric bacterial meningitis Carmen Walsh Newsletter Article 18 February 2013 Pages: 13 - 14
Which therapy for reducing the recurrence of duodenal ulcers? Newsletter Article 18 February 2013 Pages: 14 - 14
… but benefits of ‘Adderall’ may be longer lasting Newsletter Article 18 February 2013 Pages: 15 - 15
Combined chemotherapy effective in orofacial cancer Newsletter Article 18 February 2013 Pages: 15 - 15
Cyclosporin plus antithymocyte globulin in aplastic anaemia Newsletter Article 18 February 2013 Pages: 16 - 16
IFN-α beneficial in melanoma and renal cell cancer Newsletter Article 18 February 2013 Pages: 18 - 18
Corticosteroids may modulate fetoplacental vascular resistance Newsletter Article 18 February 2013 Pages: 20 - 20
NSCLC outcome not influenced by paclitaxel concentrations Newsletter Article 18 February 2013 Pages: 20 - 20
